Ceftazidime-Avibactam as Osteomyelitis Therapy: A Miniseries and Review of the Literature
Bone and joint infections (BJIs) caused by multidrug-resistant gram-negative bacteria are becoming a concern due to limited therapeutic options. Although not approved for these indications, an ever-growing amount of evidence supports the efficacy and safety of ceftazidime-avibactam as a therapy for...
Saved in:
Main Authors: | Alessandro Mancuso (Author), Luca Pipitò (Author), Raffaella Rubino (Author), Salvatore Antonino Distefano (Author), Donatella Mangione (Author), Antonio Cascio (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Ceftazidime-Avibactam Therapy Versus Ceftazidime-Avibactam-Based Combination Therapy in Patients With Carbapenem-Resistant Gram-Negative Pathogens: A Meta-Analysis
by: Dan Li, et al.
Published: (2021) -
Analysis of the clinical application of ceftazidime-avibactam in China
by: Qing Wang, et al.
Published: (2022) -
Ceftazidime-Avibactam Combination Therapy Compared to Ceftazidime-Avibactam Monotherapy for the Treatment of Severe Infections Due to Carbapenem-Resistant Pathogens: A Systematic Review and Network Meta-Analysis
by: Marco Fiore, et al.
Published: (2020) -
Diencephalic syndrome in childhood, a challenging cause of failure to thrive: miniseries and literature review
by: Sandra Trapani, et al.
Published: (2022) -
Ceftazidime-avibactam induced renal disorders: past and present
by: Yanrong Shi, et al.
Published: (2024)